You are here: Industry Insights > Novo Nordisk

News List

Novo buys into EpiDestiny’s experimental sickle cell therapy pharmatimes
July 18, 2018
Danish drugmaker Novo Nordisk has bought a global licence for EpiDestiny’s sickle cell disease (SCD) programme, EPI01.
Kallyope and Novo Nordisk announce collaboration to discover novel therapeutics for obesity and diabetes worldpharmanews
July 05, 2018
Kallyope, Inc and Novo Nordisk A/S today announced that they have entered into a research collaboration and option agreement to discover novel peptide therapeutics to treat obesity and diabetes. Kallyope will receive an upfront payment and research suppor
Novo Nordisk trumpets more Januvia-topping data for oral semaglutide fiercepharma
July 02, 2018
Just eight days after posting a trial win over Merck diabetes stalwart Januvia, Novo Nordisk candidate semaglutide is back with another.
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia fiercepharma
June 25, 2018
Once it wins approval, Novo Nordisk’s highly anticipated oral diabetes drug semaglutide will go up against some stiff competition. But the drugmaker just showed that its up-and-comer can take the heat.
Market leader Novo Nordisk still has lots of upside in China's rapidly growing diabetes market fiercepharma
June 08, 2018
One question Bernstein often gets from investors is why China isn’t a bigger part of Novo Nordisk today, given its large diabetic population.
Novo Nordisk achieves milestone in stem cell-based therapies financialexpress
May 21, 2018
Novo Nordisk has recently announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes into other serious chronic diseases.
Novo Nordisk increases commitment to cell therapies biospectrumasia
May 17, 2018
The projects aim to treat Parkinson's disease, heart failure and loss of vision, all severe chronic conditions.
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 11, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia in diabetes.
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 08, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden ...
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 03, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page